Medical Weight Loss for Daly City, California Residents

Daly City, California residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Daly City through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Open to all of California, including Daly City: our Costa Mesa, California physicians treat patients statewide by telehealth, so distance from our office never changes the care you receive. Doctor review just $119 (medication separate).

Why Daly City Residents Choose New Hope Weight Loss

What draws a lot of Daly City patients to New Hope is the honest pricing. Semaglutide starts at $166 a month and tirzepatide at $233 a month, with a $119 physician visit, and that is the whole conversation. There is no surprise line item, no distance surcharge for living outside Costa Mesa, and no pressure to buy a bundle you did not ask for. You see the real numbers before you commit, which is how it should be.

From our Costa Mesa, California practice, we provide Daly City with physician-supervised GLP-1 care entirely by telehealth. Treatment is prescribed only after Dr. Sharma's review, and medication ships discreetly to your door.

Living in Daly City, California means your weight-loss care comes to you online rather than the other way around, with Dr. Anjmun Sharma supervising each step from our Costa Mesa practice. We care for patients throughout downtown, the Westlake district, and the northern San Mateo County peninsula. Refills are tracked for you and reshipped on schedule, so nothing lapses while you are busy living your life in Daly City.

Whether you live in central Daly City or out toward the edges of California, you see the same physician, Dr. Anjmun Sharma, and pay the same flat pricing with no distance surcharge. Because every Daly City visit happens by video, there is no local office to drive to and no travel cost added to your $119 review. California is our home state and our physical clinic sits in Costa Mesa, but we care for patients across the rest of the state by secure telehealth.

GLP-1 Weight Loss Programs Available

Semaglutide 90-Day Metabolic Reset, from $166/mo

Most Daly City patients start here. Semaglutide shares its active ingredient with Wegovy and Ozempic, and in branded-drug trials people lost an average of 15 to 17 percent of body weight. Our program runs $499 for 90 days, with Dr. Sharma adjusting your dose each month by telehealth. Results vary, and compounded semaglutide is not FDA-approved or brand-identical.

Tirzepatide, from $233/mo

Tirzepatide works on two hunger pathways at once, GLP-1 and GIP. In trials of the branded drug, qualified patients reached up to 22.5 percent body-weight loss, which is a high-dose figure and not typical. It shares its active ingredient with Mounjaro and Zepbound.

$119 physician review. Medication is billed separately. We accept HSA, FSA, Klarna, and Affirm, with no surcharge for treating you in Daly City by telehealth.

How Telehealth Works for Daly City

Telehealth means your weight-loss care travels to you instead of the other way around. Patients across Daly City and the rest of start with a detailed online quiz covering medical history and goals. Dr. Anjmun Sharma personally reviews each intake and connects by secure video, usually inside 48 hours, to decide together whether a compounded GLP-1 is right. When she writes a prescription, the medication is filled by a state-licensed 503(a) pharmacy and mailed to your Daly City door in temperature-controlled cold-pack packaging. Ongoing follow-ups also happen by video, keeping your plan on track without a single in-person appointment.

Frequently Asked Questions, Daly City

Where is the closest New Hope Weight Loss to Daly City?

Our clinic is physically located in Costa Mesa, California, and it is the only one we operate. Distance is not a barrier, though, because Daly City, California patients are cared for through telehealth. During a video consultation, Dr. Anjmun Sharma reviews your situation and confirms your eligibility for a compounded GLP-1 plan.

Is in-person attendance required for patients from Daly City?

It is not. We run a complete telehealth model, so people in Daly City handle everything from home. Your appointment with Dr. Sharma, your paperwork, and your follow-ups are all online. Approved medication is shipped to Daly City using cold-pack insulation that keeps it stable until it reaches you.

What should a Daly City patient budget for care?

The visit with the physician is $119. Semaglutide starts at $166 monthly or $499 for the 90-day program, and tirzepatide at $233 monthly. The drug is billed apart from the consult. We take HSA, FSA, Klarna, and Affirm, and Daly City patients are not charged any extra distance fee.

What areas of Daly City do you serve?

We serve patients from across Daly City by telehealth, including downtown, the Westlake district, and the northern San Mateo County peninsula.

Who qualifies for the program in Daly City?

Eligibility for Daly City patients is decided by Dr. Sharma during the medical review, based on your health history, current medications, and goals. The $119 visit is not charged if you are not a candidate, and there is no obligation to continue.

Daly City Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Daly City, California by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.